Texas Permanent School Fund’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17,419
| Closed | -$373K | – | 1519 |
|
|
2023
Q2 | $373K | Sell |
17,419
-188
| -1% | -$5.54K | ﹤0.01% | 1478 |
|
|
2023
Q1 | $712K | Buy |
17,607
+4,510
| +34% | +$215K | 0.01% | 1342 |
|
|
2022
Q4 | $609K | Sell |
13,097
-919
| -7% | -$41.9K | 0.01% | 1295 |
|
|
2022
Q3 | $727K | Buy |
14,016
+692
| +5% | +$40.4K | 0.01% | 1230 |
|
|
2022
Q2 | $630K | Buy |
13,324
+385
| +3% | +$20.9K | 0.01% | 1293 |
|
|
2022
Q1 | $921K | Sell |
12,939
-31
| -0.2% | -$2.02K | 0.01% | 1229 |
|
|
2021
Q4 | $970K | Sell |
12,970
-339
| -3% | -$26.6K | 0.01% | 1227 |
|
|
2021
Q3 | $756K | Sell |
13,309
-85
| -0.6% | -$4.2K | 0.01% | 1302 |
|
|
2021
Q2 | $589K | Sell |
13,394
-19
| -0.1% | -$930 | 0.01% | 1383 |
|
|
2021
Q1 | $662K | Sell |
13,413
-936
| -7% | -$46.7K | 0.01% | 1331 |
|
|
2020
Q4 | $604K | Sell |
14,349
-2,338
| -14% | -$103K | 0.01% | 1329 |
|
|
2020
Q3 | $764K | Buy |
16,687
+3,885
| +30% | +$188K | 0.01% | 1212 |
|
|
2020
Q2 | $643K | Sell |
12,802
-757
| -6% | -$39.2K | 0.01% | 1215 |
|
|
2020
Q1 | $697K | Buy |
13,559
+2,630
| +24% | +$140K | 0.01% | 1101 |
|
|
2019
Q4 | $675K | Buy |
10,929
+78
| +0.7% | +$4.84K | 0.01% | 1234 |
|
|
2019
Q3 | $652K | Buy |
10,851
+38
| +0.4% | +$2.82K | 0.01% | 1234 |
|
|
2019
Q2 | $912K | Buy |
10,813
+120
| +1% | +$10.8K | 0.01% | 1105 |
|
|
2019
Q1 | $1.02M | Buy |
10,693
+397
| +4% | +$35.6K | 0.02% | 1068 |
|
|
2018
Q4 | $729K | Buy |
10,296
+420
| +4% | +$32.2K | 0.01% | 1150 |
|
|
2018
Q3 | $844K | Buy |
9,876
+549
| +6% | +$55K | 0.01% | 1181 |
|
|
2018
Q2 | $1.08M | Sell |
9,327
-182
| -2% | -$18.2K | 0.01% | 1079 |
|
|
2018
Q1 | $769K | Sell |
9,509
-142
| -1% | -$10.9K | 0.01% | 1187 |
|
|
2017
Q4 | $566K | Sell |
9,651
-772
| -7% | -$38.7K | 0.01% | 1306 |
|
|
2017
Q3 | $488K | Buy |
10,423
+277
| +3% | +$11.1K | 0.01% | 1360 |
|
|
2017
Q2 | $365K | Buy |
10,146
+85
| +0.8% | +$2.72K | ﹤0.01% | 1412 |
|
|
2017
Q1 | $310K | Sell |
10,061
-74
| -0.7% | -$2.31K | ﹤0.01% | 1429 |
|
|
2016
Q4 | $340K | Sell |
10,135
-451
| -4% | -$12.9K | ﹤0.01% | 1428 |
|
|
2016
Q3 | $282K | Buy |
10,586
+439
| +4% | +$10.2K | ﹤0.01% | 1435 |
|
|
2016
Q2 | $224K | Sell |
10,147
-419
| -4% | -$11K | ﹤0.01% | 1452 |
|
|
2016
Q1 | $310K | Sell |
10,566
-297
| -3% | -$8.27K | ﹤0.01% | 1401 |
|
|
2015
Q4 | $359K | Buy |
10,863
+34
| +0.3% | +$1.11K | ﹤0.01% | 1385 |
|
|
2015
Q3 | $391K | Buy |
+10,829
| New | +$465K | 0.01% | 1369 |
|
Other funds holding ENTA
AC
FCM
B
KAM
Texas Permanent School Fund's ENTA Position: Q3 2023 in Review
Texas Permanent School Fund sold out of Enanta Pharmaceuticals (ENTA) in Q3 2023, closing a stake of 17,419 shares — an estimated $373K sold.
Texas Permanent School Fund first reported a position in ENTA in Q3 2015 and held it in 32 quarters. The position peaked at $1.08M in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q3 2023.
- Texas Permanent School Fund reported no remaining Enanta Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
- Texas Permanent School Fund sold 17,419 Enanta Pharmaceuticals shares in Q3 2023, an estimated $373K.
- Texas Permanent School Fund first reported a position in Enanta Pharmaceuticals in Q3 2015 and held it in 32 quarters.
- Texas Permanent School Fund's Enanta Pharmaceuticals position peaked at $1.08M in Q2 2018.
- 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2023.
Based on Texas Permanent School Fund's 13F filing for Q3 2023, filed 9 Nov 2023.